$CRESY

Elsztain Alejandro Gustavo purchased $199K of CRESY

Elsztain Alejandro Gustavo purchased 18,200 shares of CRESUD INC (CRESY) at $10.95 ($0.20M total) on 2026-06-05.

Original reporting
SEC EDGAR · Elsztain Alejandro Gustavo
Published Jun 5, 2026, 8:17 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 5, 2026, 8:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CRESY
Bullish
medium confidence
Mentioned
$CRESY
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CRESYBullishLow
01

Why it matters

The only new information is the director’s disclosed open-market purchase (18,200 shares at $10.95), which may slightly improve sentiment but does not change fundamentals on its own.

02

Market read

Traders may treat this as a minor bullish sentiment input for CRESY, but it is unlikely to drive a major repricing without corroborating company news.

03

What to watch

The article provides purchase price and size but no rationale; also, insider buying is less informative than sales for timing/valuation signals.

Relevance 7/10Novelty 7/10Timing: Filed 2026-06-05; usable for same-day positioning around the disclosure window.

Background

The article reports an SEC Form 4 insider transaction for CRESUD Inc, filed on 2026-06-05.

Company-level read

Ticker impact

$CRESYBullishMedium confidence
Context

CRESUD Inc (CRESY) is the issuer of the SEC Form 4 showing a director’s $199K open-market purchase on 2026-06-05.

Expected impact

Small, short-lived positive drift possible; no strong directional conviction from this filing alone.

Evidence & confidence

The filing is a disclosed ownership change (director purchase) with a specific date/size, but no accompanying company-specific operational or financial news.

Market effects

Limited read-across; insider buying in a single issuer typically does not reprice the broader real-estate/Argentina-exposed complex without additional fundamentals.

Potentially small sentiment effect for Argentina-linked real-estate sentiment, but no direct macro/regulatory trigger is cited.

Low—this is company-specific insider activity with no stated global catalyst.

Counterpoint

Insider purchases can be routine liquidity/portfolio rebalancing and may not reflect near-term fundamentals, especially without a 10b5-1 plan context.

Key entities

  • CRESUD Inc

    Subject of the SEC Form 4 insider transaction disclosure.

  • Elsztain Alejandro Gustavo

    Director who purchased 18,200 shares open-market on 2026-06-05.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CRESYMed

CRESUD INC (CRESY): Financial results for FY2026

CRESUD INC (CRESY) furnished an SEC Form 6-K — earnings release. Yes o No x CRESUD S.A.C.I.F. and A. (THE “COMPANY”) REPORT ON FORM 6-K Attached is the English translation of the letter filed with the Comision Nacional de Valores and Bolsas y Mercados Argentinos S.A. on September 7, 2026. By letter dated September 7, 2026, the company reported

$ASPEMedAI 8/10

ARCH Venture Fund X, L.P. (CRANDELL KEITH, Burow Kristina) purchased $18.0M of ASPE (indirect holdings)

ARCH Venture Fund X, L.P. purchased 1,200,000 indirectly-held shares of Aspen Neuroscience, Inc. (ASPE) at $15.00 ($18.00M total) on 2026-11-02. Filed jointly with ARCH Venture Fund X Overage, L.P. (10% owner), ARCH Venture Partners X, L.P. (10% owner), ARCH Venture Partners X Overage, L.P. (10% owner), ARCH Venture Partners X, LLC (10% owner), CRANDELL KEITH (10% owner), Burow Kristina (10% owner), GILLIS STEVEN (10% owner) and NELSEN ROBERT (10% owner).

$ASPELow

ARCH Venture Fund X, L.P. (CRANDELL KEITH, Burow Kristina) purchased $2.0M of ASPE

ARCH Venture Fund X, L.P. purchased 133,333 shares of Aspen Neuroscience, Inc. (ASPE) at $15.00 ($2.00M total) across 2 trades on 2026-11-02. Filed jointly with ARCH Venture Fund X Overage, L.P. (10% owner), ARCH Venture Partners X, L.P. (10% owner), ARCH Venture Partners X Overage, L.P. (10% owner), ARCH Venture Partners X, LLC (10% owner), CRANDELL KEITH (10% owner), Burow Kristina (10% owner), GILLIS STEVEN (10% owner) and NELSEN ROBERT (10% owner).